Top 5 gynecologic studies from October 2019

November 11, 2019

a BELS-certified medical writer and editor, and an editorial consultant for Contemporary OB/GYN

Ben Schwartz

Ben Schwartz is Associate Editor, Contemporary OB/GYN.

Ranging from sexual function among cancer patients to how lifetime estrogen exposure affects late-life cognition to state strategies to address opioid use, these were Contemporary OB/GYN's selections for the top gynecologic studies published in October 2019.

Sexual function among cancer patients

Presenting at the 2019 ASRM Scientific Congress & Expo, researchers from the University of Pennsylvania explored circulating androgen levels before and after cancer therapy, as well as sexual function.

©Photographee.eu - stock.adobe.com

Has closure of women’s health clinics affected cervical cancer screening?

State-level restrictions on reproductive services led to shuttering of nearly 100 women’s health clinics in the United States over a 4-year period.

©ibreakstock - stock.adobe.com

CDC develops state strategies to address opioid use

To combat the rise of opioid use disorder (OUD), the Centers for Disease Control and Prevention has partnered with the Association of State and Territorial Health Officials to launch the Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Initiative Learning Community.

Steve Heap - shutterstock.com

Sexual minority women’s experiences of health care

Researchers have undertaken a systematic review of how sexual minority women (SMW) experience health care in the UK and the results suggest a need for explicit and consistent education for health care professionals there.

How does lifetime estrogen exposure affect late-life cognition?

Results from a recently published study in Menopause indicate that higher endogenous estrogen exposure (EEE) and hormone therapy (HT) may lead to better cognition for women in later life.